Home Compare NOVN.SW vs ZTS
Stock Comparison · Single-driver result

Novartis vs Zoetis: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Zoetis carrying a narrow edge on stability. Novartis still has the edge on stability, which keeps the comparison from looking entirely one-sided. In the market, Novartis carries the stronger setup — intact trend against Zoetis's broken trend. That leaves a split case: the structural lead stays with Zoetis, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

Stability points more clearly toward Novartis AG, even if the broader score still leans toward Zoetis Inc..

Trajectory Similarity
0.64
Moderately similar
Peer-set rank: #11
within Novartis AG's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

A moderate similarity means the pair is structurally comparable, but not a near-twin trajectory match.

The match is driven mainly by revenue stability and capital structure.

Similarity drivers
revenue stabilitycapital structure
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
NOVN.SW
Novartis AG
55
Peer-Score
Signal qualityHigh
vs
ZTS
Zoetis Inc.
59
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in stability.

Dimension spread: NOVN.SW vs ZTS Profitability 60 85 Stability 78 23 Valuation 55 82 Growth 22 20 NOVN.SW ZTS
Gap Ranking
#1 Stability +55
#2 Valuation +27
#3 Profitability +25
#4 Growth +2
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for NOVN.SW and ZTS Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer NOVN.SWZTS Relative valuation Structural strength

Novartis AG still looks stronger overall, though current pricing looks more supportive for Zoetis Inc..

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Stability
Novartis AG ranks near the top of the group on stability; Zoetis Inc. sits in the weaker half.
Valuation
On valuation, the same pattern holds: both are strong, but Zoetis Inc. still leads clearly.
Stability — Dominant Gap
NOVN.SW
78
ZTS
23
Gap+55in favour of NOVN.SW

The stability gap is very wide, with the stronger side looking materially steadier through time.

What keeps the gap from being one-sided

On the market side, Novartis carries the stronger trend while Zoetis's trend has broken — the market setup does not confirm the structural advantage.

What this means for the comparison

The lead is built on both stability and valuation — though stability still provides a counterweight.

Explore full peer positioning in AssetNext

Break down the NOVN.SW vs ZTS comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how NOVN.SW and ZTS each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.